Publication | Closed Access
Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results
281
Citations
25
References
2024
Year
Cancer ImmunosurveillanceGliomaImmunologyTrial Interim ResultsImmune Checkpoint InhibitorHigh-grade GliomasCancer TreatmentRecurrent GlioblastomaImmunotherapyMedicineCell BiologyPhase 1
| Year | Citations | |
|---|---|---|
Page 1
Page 1